Noerr advises US investor Casa Verde Capital on investment in Cansativa

Led by our Berlin partner Felix Blobel, our firm has advised US investor Casa Verde Capital on a Series B investment in cannabis start-up Cansativa Group.

The Los Angeles, California-based venture capital firm, one of the largest cannabis-focused venture capitalist in the United States, is the lead investor in the Series B funding round of Cansativa Group, a B2B medical cannabis platform based in Mörfelden-Walldorf, Hesse.

Together with Argonautic Ventures and the Munich-based family office Alluti, Casa Verde Capital is investing almost 13 million euros. This is Casa Verde's largest investment in Germany and Europe to date.

Cansativa is active at all stages of the value chain: from importing the goods to distributing them to thousands of pharmacies, including logistics. In addition to cannabis flowers and medicinal cannabis products, the Cansativa Group distributes accessories and add-on items to pharmacies throughout Germany. In addition, Cansativa offers companies a platform for all aspects of market access, cannabis distribution, contract logistics and packaging services.

Noerr is one of the leading law firms in the field of venture capital and growth capital and regularly advises investors and growth companies on large-volume and complex financings and exit transactions.

German legal directory JUVE rates our venture capital practice with five stars in the Handbook of Business Law Firms and ranks Felix Blobel among the "leading advisors for venture capital".

Advisor Casa Verde Capital, LLC: Noerr Partnerschaftsgesellschaft mbB

Lead: Felix Blobel (Private Equity, Berlin)

Private Equity
Daniel Fuchs (Berlin)

Healthcare
Susann Jahn (Dresden)

Noerr collaborated on this transaction with leading Canadian law firm Osler, Hoskin & Harcourt LLP (Gary Marshall, Emerging and High Growth Companies, Toronto).